These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

681 related articles for article (PubMed ID: 27196573)

  • 1. Tumour CD274 (PD-L1) expression and T cells in colorectal cancer.
    Masugi Y; Nishihara R; Yang J; Mima K; da Silva A; Shi Y; Inamura K; Cao Y; Song M; Nowak JA; Liao X; Nosho K; Chan AT; Giannakis M; Bass AJ; Hodi FS; Freeman GJ; Rodig S; Fuchs CS; Qian ZR; Ogino S
    Gut; 2017 Aug; 66(8):1463-1473. PubMed ID: 27196573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fusobacterium nucleatum and T Cells in Colorectal Carcinoma.
    Mima K; Sukawa Y; Nishihara R; Qian ZR; Yamauchi M; Inamura K; Kim SA; Masuda A; Nowak JA; Nosho K; Kostic AD; Giannakis M; Watanabe H; Bullman S; Milner DA; Harris CC; Giovannucci E; Garraway LA; Freeman GJ; Dranoff G; Chan AT; Garrett WS; Huttenhower C; Fuchs CS; Ogino S
    JAMA Oncol; 2015 Aug; 1(5):653-61. PubMed ID: 26181352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin Use and Colorectal Cancer Survival According to Tumor CD274 (Programmed Cell Death 1 Ligand 1) Expression Status.
    Hamada T; Cao Y; Qian ZR; Masugi Y; Nowak JA; Yang J; Song M; Mima K; Kosumi K; Liu L; Shi Y; da Silva A; Gu M; Li W; Keum N; Zhang X; Wu K; Meyerhardt JA; Giovannucci EL; Giannakis M; Rodig SJ; Freeman GJ; Nevo D; Wang M; Chan AT; Fuchs CS; Nishihara R; Ogino S
    J Clin Oncol; 2017 Jun; 35(16):1836-1844. PubMed ID: 28406723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review.
    Nosho K; Baba Y; Tanaka N; Shima K; Hayashi M; Meyerhardt JA; Giovannucci E; Dranoff G; Fuchs CS; Ogino S
    J Pathol; 2010 Dec; 222(4):350-66. PubMed ID: 20927778
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Hamada T; Zhang X; Mima K; Bullman S; Sukawa Y; Nowak JA; Kosumi K; Masugi Y; Twombly TS; Cao Y; Song M; Liu L; da Silva A; Shi Y; Gu M; Li W; Koh H; Nosho K; Inamura K; Keum N; Wu K; Meyerhardt JA; Kostic AD; Huttenhower C; Garrett WS; Meyerson M; Giovannucci EL; Chan AT; Fuchs CS; Nishihara R; Giannakis M; Ogino S
    Cancer Immunol Res; 2018 Nov; 6(11):1327-1336. PubMed ID: 30228205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of autophagy status with amount of Fusobacterium nucleatum in colorectal cancer.
    Haruki K; Kosumi K; Hamada T; Twombly TS; Väyrynen JP; Kim SA; Masugi Y; Qian ZR; Mima K; Baba Y; da Silva A; Borowsky J; Arima K; Fujiyoshi K; Lau MC; Li P; Guo C; Chen Y; Song M; Nowak JA; Nishihara R; Yanaga K; Zhang X; Wu K; Bullman S; Garrett WS; Huttenhower C; Meyerhardt JA; Giannakis M; Chan AT; Fuchs CS; Ogino S
    J Pathol; 2020 Apr; 250(4):397-408. PubMed ID: 31880318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor PDCD1LG2 (PD-L2) Expression and the Lymphocytic Reaction to Colorectal Cancer.
    Masugi Y; Nishihara R; Hamada T; Song M; da Silva A; Kosumi K; Gu M; Shi Y; Li W; Liu L; Nevo D; Inamura K; Cao Y; Liao X; Nosho K; Chan AT; Giannakis M; Bass AJ; Hodi FS; Freeman GJ; Rodig SJ; Fuchs CS; Qian ZR; Nowak JA; Ogino S
    Cancer Immunol Res; 2017 Nov; 5(11):1046-1055. PubMed ID: 29038297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis.
    Mima K; Nishihara R; Qian ZR; Cao Y; Sukawa Y; Nowak JA; Yang J; Dou R; Masugi Y; Song M; Kostic AD; Giannakis M; Bullman S; Milner DA; Baba H; Giovannucci EL; Garraway LA; Freeman GJ; Dranoff G; Garrett WS; Huttenhower C; Meyerson M; Meyerhardt JA; Chan AT; Fuchs CS; Ogino S
    Gut; 2016 Dec; 65(12):1973-1980. PubMed ID: 26311717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inverse relationship between
    Ugai T; Shimizu T; Kawamura H; Ugai S; Takashima Y; Usui G; Väyrynen JP; Okadome K; Haruki K; Akimoto N; Masugi Y; da Silva A; Mima K; Zhang X; Chan AT; Wang M; Garrett WS; Freeman GJ; Meyerhardt JA; Nowak JA; Song M; Giannakis M; Ogino S
    Clin Transl Immunology; 2023; 12(8):e1453. PubMed ID: 37538192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor SQSTM1 (p62) expression and T cells in colorectal cancer.
    Kosumi K; Masugi Y; Yang J; Qian ZR; Kim SA; Li W; Shi Y; da Silva A; Hamada T; Liu L; Gu M; Twombly TS; Cao Y; Barbie DA; Nosho K; Baba H; Garrett WS; Meyerhardt JA; Giovannucci EL; Chan AT; Fuchs CS; Ogino S; Nishihara R
    Oncoimmunology; 2017; 6(3):e1284720. PubMed ID: 28405513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA MIR21 and T Cells in Colorectal Cancer.
    Mima K; Nishihara R; Nowak JA; Kim SA; Song M; Inamura K; Sukawa Y; Masuda A; Yang J; Dou R; Nosho K; Baba H; Giovannucci EL; Bowden M; Loda M; Giannakis M; Bass AJ; Dranoff G; Freeman GJ; Chan AT; Fuchs CS; Qian ZR; Ogino S
    Cancer Immunol Res; 2016 Jan; 4(1):33-40. PubMed ID: 26419959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour budding, poorly differentiated clusters, and T-cell response in colorectal cancer.
    Fujiyoshi K; Väyrynen JP; Borowsky J; Papke DJ; Arima K; Haruki K; Kishikawa J; Akimoto N; Ugai T; Lau MC; Gu S; Shi S; Zhao M; Da Silva AFL; Twombly TS; Nan H; Meyerhardt JA; Song M; Zhang X; Wu K; Chan AT; Fuchs CS; Lennerz JK; Giannakis M; Nowak JA; Ogino S
    EBioMedicine; 2020 Jul; 57():102860. PubMed ID: 32652320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TIME (Tumor Immunity in the MicroEnvironment) classification based on tumor
    Hamada T; Soong TR; Masugi Y; Kosumi K; Nowak JA; da Silva A; Mu XJ; Twombly TS; Koh H; Yang J; Song M; Liu L; Gu M; Shi Y; Nosho K; Morikawa T; Inamura K; Shukla SA; Wu CJ; Garraway LA; Zhang X; Wu K; Meyerhardt JA; Chan AT; Glickman JN; Rodig SJ; Freeman GJ; Fuchs CS; Nishihara R; Giannakis M; Ogino S
    Oncoimmunology; 2018; 7(7):e1442999. PubMed ID: 29900052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implication of programmed cell death ligand 1 expression in tumor recurrence and prognosis in rectal cancer with neoadjuvant chemoradiotherapy.
    Saigusa S; Toiyama Y; Tanaka K; Inoue Y; Mori K; Ide S; Imaoka H; Kawamura M; Mohri Y; Kusunoki M
    Int J Clin Oncol; 2016 Oct; 21(5):946-952. PubMed ID: 26919982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA let-7, T Cells, and Patient Survival in Colorectal Cancer.
    Dou R; Nishihara R; Cao Y; Hamada T; Mima K; Masuda A; Masugi Y; Shi Y; Gu M; Li W; da Silva A; Nosho K; Zhang X; Meyerhardt JA; Giovannucci EL; Chan AT; Fuchs CS; Qian ZR; Ogino S
    Cancer Immunol Res; 2016 Nov; 4(11):927-935. PubMed ID: 27737877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma 25-hydroxyvitamin D and colorectal cancer risk according to tumour immunity status.
    Song M; Nishihara R; Wang M; Chan AT; Qian ZR; Inamura K; Zhang X; Ng K; Kim SA; Mima K; Sukawa Y; Nosho K; Fuchs CS; Giovannucci EL; Wu K; Ogino S
    Gut; 2016 Feb; 65(2):296-304. PubMed ID: 25591978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of
    Ugai T; Zhao M; Shimizu T; Akimoto N; Shi S; Takashima Y; Zhong R; Lau MC; Haruki K; Arima K; Fujiyoshi K; Langworthy B; Masugi Y; da Silva A; Nosho K; Baba Y; Song M; Chan AT; Wang M; Meyerhardt JA; Giannakis M; Väyrynen JP; Nowak JA; Ogino S
    Oncoimmunology; 2021; 10(1):1956173. PubMed ID: 34377593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD274, LAG3, and IDO1 expressions in tumor-infiltrating immune cells as prognostic biomarker for patients with MSI-high colon cancer.
    Lee SJ; Jun SY; Lee IH; Kang BW; Park SY; Kim HJ; Park JS; Choi GS; Yoon G; Kim JG
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1005-1014. PubMed ID: 29520442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic implication of CD274 (PD-L1) protein expression in tumor-infiltrating immune cells for microsatellite unstable and stable colorectal cancer.
    Lee KS; Kwak Y; Ahn S; Shin E; Oh HK; Kim DW; Kang SB; Choe G; Kim WH; Lee HS
    Cancer Immunol Immunother; 2017 Jul; 66(7):927-939. PubMed ID: 28405764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Programmed cell death-ligand 1 expression is associated with a favourable immune microenvironment and better overall survival in stage I pulmonary squamous cell carcinoma.
    Yang CY; Lin MW; Chang YL; Wu CT; Yang PC
    Eur J Cancer; 2016 Apr; 57():91-103. PubMed ID: 26901614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.